Home›Companies›Biotech & Pharma›Enfuego Therapeutics

Enfuego Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 28, 2025·Suggest an edit

About Enfuego Therapeutics

Enfuego Therapeutics is a private company based in Pittsboro, North Carolina, incorporated in 2021 in Delaware. It has reported $1,000,000 raised in one offering on Form D since June 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 15, 2021Jun 28, 2021amended Oct 28, 2025$1,000,000of $2.5M target12$83,333Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Enfuego Therapeutics's Form D filed Oct 28, 2025.

JM
Joe McMahon
Director
CP
Chad Pecot
President and director
MD
Michael Dombeck
Executive officer and director
SM
Sue Mahony
Director

Sources

  1. SECEnfuego Therapeutics, Inc. Form D, filed Jun 28, 2021
  2. SECEnfuego Therapeutics, Inc. filing history